Fate Therapeutics, Inc.FATENASDAQ
Loading
Revenue ContractionContracting
Percentile Rank57
3Y CAGR-59.0%
5Y CAGR-26.7%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-59.0%/yr
vs +112.3%/yr prior
5Y CAGR
-26.7%/yr
Recent deceleration
Acceleration
-171.3pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.65M | -51.2% |
| 2024 | $13.63M | -78.5% |
| 2023 | $63.53M | -34.0% |
| 2022 | $96.30M | +72.4% |
| 2021 | $55.85M | +77.7% |
| 2020 | $31.43M | +194.3% |
| 2019 | $10.68M | +125.3% |
| 2018 | $4.74M | +15.4% |
| 2017 | $4.11M | -6.7% |
| 2016 | $4.40M | - |